Aytu BioPharma Inc (AYTU)
2.91
+0.07
(+2.46%)
USD |
NASDAQ |
Apr 26, 11:11
Aytu BioPharma Revenue (TTM): 98.50M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 98.50M |
| September 30, 2023 | 101.84M |
| June 30, 2023 | 107.40M |
| March 31, 2023 | 104.12M |
| December 31, 2022 | 105.58M |
| September 30, 2022 | 102.43M |
| June 30, 2022 | 96.67M |
| March 31, 2022 | 92.70M |
| December 31, 2021 | 81.99M |
| September 30, 2021 | 74.01M |
| June 30, 2021 | 65.63M |
| March 31, 2021 | 57.01M |
| December 31, 2020 | 51.68M |
| September 30, 2020 | 39.71M |
| June 30, 2020 | 27.63M |
| March 31, 2020 | 14.49M |
| December 31, 2019 | 8.709M |
| Date | Value |
|---|---|
| September 30, 2019 | 7.328M |
| June 30, 2019 | 7.320M |
| March 31, 2019 | 6.530M |
| December 31, 2018 | 4.759M |
| September 30, 2018 | 4.015M |
| June 30, 2018 | 3.659M |
| March 31, 2018 | 3.57M |
| December 31, 2017 | 3.857M |
| September 30, 2017 | 3.60M |
| June 30, 2017 | 3.222M |
| March 31, 2017 | 3.323M |
| December 31, 2016 | 3.098M |
| September 30, 2016 | 2.773M |
| June 30, 2016 | 2.563M |
| March 31, 2016 | 1.807M |
| December 31, 2015 | 1.163M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
7.320M
Minimum
Jun 2019
107.40M
Maximum
Jun 2023
65.51M
Average
74.01M
Median
Sep 2021
Revenue (TTM) Benchmarks
| Regen BioPharma Inc | 0.2366M |
| Clearday Inc | 7.543M |
| Bioxytran Inc | -- |
| Shuttle Pharmaceuticals Holdings Inc | -- |
| CEL-SCI Corp | -- |